CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 25,000 shares at an average $2.41 ($60,350)
- 4 Open-market buy Director bought 5,000 shares at $2.40 ($12,000)
- 4 Exercise or conversion Chief Scientific Officer acquired 6,410 shares (option exercise)
- 4 Grant or award Chief Executive Officer acquired 662 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Executive VP, Research acquired 657 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 50,000 shares at $2.85 ($142,250)
- 4 Open-market buy Director bought 30,000 shares at $3.29 ($98,700)
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at $3.29 ($16,442)
- 4 Exercise or conversion Executive VP, Research acquired 3,700 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 7,881 shares (option exercise)
- 4 Open-market buy Director bought 1,371,362 shares at $2.99 ($4,100,372)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $2.88 ($28,800)
- 4 Open-market sale General Counsel sold 2,614 shares at $2.69 ($7,032)
- 4 Grant or award Chief Medical Officer acquired 11,699 shares (grant or award)
Page 7 of 11 · 211 filings